Please login to the form below

Not currently logged in
Email:
Password:

P&G signs bioinformatics deal to speed new product research

Will use Eagle Genomics' software platform Eaglecore

edit-PG_logo 

Procter & Gamble (P&G) has signed a four-year agreement to use bioinformatics software to help boost the development of new products including pharmaceuticals, consumer goods and biofuels.

The firm will use Eagle Genomics' secure, cloud-based, Eaglecore platform to organise existing data and integrate existing data with new analysis from across the company.

Dr Abel Ureta-Vidal, CEO of Eagle, said: “Eaglecore is an extremely powerful platform and will have a major impact on P&G's approach to their current research projects.

“By using out platform, P&G will be able to better reference, manage and use all of their data to develop new insights and products, saving both time and development costs.”

The deal will see P&G take a four-year license for an undisclosed sum, which will include additional data curation services. The agreement follows a long partnership between the two companies involving Eagle's consultancy arm, which has been used to support past research.

Eagle, which allows large-scale genomics data and data generation technologies to be applied to world issues, was earlier this year awarded funding from the UK's Department of Health to develop proposals to help to with treating rare diseases and cancer.

Article by
Kirstie Pickering

12th December 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....

Infographics